Metabolic-associated fatty liver disease (MAFLD) is now considered the most frequent cause
of chronic liver disease in the world because of the alarming rise in obesity across the globe …

Metabolic-associated fatty liver disease (MAFLD), a recently proposed name change from
nonalcoholic fatty liver disease (NAFLD) to encompass its close association with a …

Metabolic (dysfunction)-associated fatty liver disease (MAFLD) is the most common chronic
liver disease worldwide–with an estimated global prevalence of 37%. Different from …

The obesity epidemic is one of the major health concerns of the 21st century. Nonalcoholic
fatty liver disease (NAFLD) is linked with the increased adiposity associated with obesity …

Abstract Background and Aims Metabolic-associated fatty liver disease (MAFLD) was
proposed as a better definition of nonalcoholic fatty liver disease (NAFLD) to encompass the …

Background: Metabolic (dysfunction) associated fatty liver disease (MAFLD; previously non-
alcoholic fatty liver disease [NAFLD]) affects one in four Australian adults and many children …

In 2020, an international group of experts proposed to replace the term of nonalcoholic fatty
liver disease with metabolic-associated fatty liver disease (MAFLD). This recent proposal …

Non-alcoholic fatty liver disease (NAFLD) affects almost a quarter of the world's population
and is the most common cause of chronic liver disease in children and adolescents. The …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease in the
world, which predispose to more serious hepatic conditions. It ranges from simple liver …

Metabolic-associated fatty liver disease (MAFLD), previously called nonalcoholic fatty liver
diseases (NAFLD), is one of the most important causes of chronic liver disease worldwide …